How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/metastasis-from-malignant-tumor-of-colon.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Metastasis from malignant tumor of colon — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metastasis from malignant tumor of colon (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Metastasis from malignant tumor of colon, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Stivarga	regorafenib	Bayer	Kinase Inhibitor	Bifunctional epoxide hydrolase 2	2012-01-01
Vegf Trap	AFLIBERCEPT	Regeneron	Vascular Endothelial Growth Factor Inhibitor	Vascular endothelial growth factor A	2011-01-01
Eloxatin	Oxaliplatin	Yakult Honsha	Platinum-based chemotherapy agent	DNA	2002-01-01
Xeloda	capecitabine	Cheplapharm	Nucleoside Metabolic Inhibitor [EPC]	Thymidylate synthase	1998-01-01
Camptosar	onivyde	Pfizer	Topoisomerase Inhibitor	Acetylcholinesterase	1996-01-01
Camptosar	irinotecan	Pfizer	Topoisomerase Inhibitor	topoisomerase I	1996-01-01
Camptosar	Irinotecan Hydrochloride	Pfizer	Topoisomerase Inhibitor	Acetylcholinesterase	1996-01-01
Carac	5-fu	Spectrum Pharms	Nucleoside Metabolic Inhibitor	Aromatase	1962-01-01
Carac	fluorouracil	Extrovis	Nucleoside Metabolic Inhibitor [EPC]	Aromatase	1962-01-01
Eylea	Eylea	Texas Retina Associates		Placenta growth factor, Vascular endothelial growth factor A, Vascular endothelial growth factor B

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 3 drugs in Metastasis from malignant tumor of colon
Cheplapharm · 1 drug in Metastasis from malignant tumor of colon
Extrovis · 1 drug in Metastasis from malignant tumor of colon
Regeneron · 1 drug in Metastasis from malignant tumor of colon
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 1 drug in Metastasis from malignant tumor of colon
Spectrum Pharms · 1 drug in Metastasis from malignant tumor of colon
Texas Retina Associates · 1 drug in Metastasis from malignant tumor of colon
Bayer · 1 drug in Metastasis from malignant tumor of colon
Yakult Honsha · 1 drug in Metastasis from malignant tumor of colon

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Metastasis from malignant tumor of colon:

Cite this brief

Drug Landscape (2026). Metastasis from malignant tumor of colon — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/metastasis-from-malignant-tumor-of-colon. Accessed 2026-06-10.

Metastasis from malignant tumor of colon full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing